Unveiling Type 5 Diabetes: A Distinct Form of the Disease

the International Diabetes Federation (IDF) has formally acknowledged a distinct form of diabetes, termed “Type 5 Diabetes,” primarily affecting thin adolescents and young adults in low- and middle-income nations.This recognition marks a notable advancement in diabetes research and patient care, largely driven by the pioneering work of Dr. Meredith Hawkins,founder of the Global Diabetes Institute at Einstein Medical College.

This newly classified diabetes is not linked to obesity, the primary driver of type 2 diabetes, but rather to malnutrition. This distinction is crucial for accurate diagnosis and effective treatment strategies.

The Global Impact and Diagnostic Challenges

Dr. Hawkins emphasizes the critical need for increased awareness, stating that Type 5 Diabetes has been substantially underdiagnosed, impacting millions globally. The IDF’s formal recognition is a pivotal step in addressing this oversight.

While type 2 diabetes remains prevalent in developing countries, a growing number of young individuals are developing diabetes due to nutritional deficiencies, not overeating. Current estimates suggest that 20 to 25 million people worldwide, predominantly in Asia and Africa, are affected by type 5 diabetes. The medical community faces challenges in effectively treating these patients, with survival rates often alarmingly low post-diagnosis.

This is an importent step to increase public attention to this health issue because it has a devastating impact on millions of patients around the world.
Dr. Meredith Hawkins, Global Diabetes Institute

A Historical Viewpoint and the Path to Recognition

The concept of malnutrition-related diabetes emerged decades ago, with the World Health Institution (WHO) acknowledging its uniqueness in 1985. However, due to limited research, it was declassified in 1999. Dr. Hawkins’ observations since 2005 highlighted the urgent need to revisit this classification.

the confusion among physicians stems from the fact that these patients do not fit the typical profiles of type 1 or type 2 diabetes. Their unique clinical presentation complicates both diagnosis and treatment.

breakthrough Research and a Paradigm Shift

In 2010, Dr. Hawkins established the global Diabetes Institute to spearhead international research into the metabolic mechanisms of this distinct form of diabetes. A pivotal study published in Diabetes Care in 2022, in collaboration with the Velor Christian Medical College in India, demonstrated that type 5 diabetes differs fundamentally from other types. The key difference lies in a severe defect in insulin secretion, rather than insulin resistance.

study reveals that these patients have serious defects in the ability of insulin to secrete. This discovery has completely changed our understanding and treatment of the cause.
Dr. Meredith Hawkins, Global Diabetes Institute

this discovery has revolutionized the understanding and treatment approach for this condition.

International Collaboration and Future Directions

Building on this evidence, Dr. Hawkins convened an international conference in India earlier this year,bringing together global experts and representatives from the IDF and the American Diabetes Association. The consensus was to recognize it as an autonomous disease type, a resolution officially adopted at the 2025 IDF World Diabetes Conference in Bangkok, Thailand.

IDF Chairman Dr. Peter Schwarz announced the formation of the Type 5 Diabetes Working Group, co-chaired by Dr. Hawkins, with the goal of developing formal diagnostic and treatment guidelines within two years. This collaborative effort aims to standardize care and improve outcomes for affected individuals.

The Urgency for Action and Hope for the Future

Dr.Hawkins emphasizes that the prevalence of type 5 diabetes rivals that of tuberculosis and approaches that of AIDS. The lack of a formal name has historically hindered diagnosis and treatment. this formal recognition is expected to accelerate research and bring hope to those suffering from this debilitating and frequently enough fatal disease.

The recognition of Type 5 diabetes represents a crucial step forward in addressing a long-neglected health issue. With increased awareness, targeted research, and standardized treatment guidelines, there is renewed hope for improving the lives of millions affected by this distinct form of diabetes. The keywords for this article are: Type 5 Diabetes, malnutrition, insulin secretion, International Diabetes Federation, IDF, Dr. Meredith Hawkins, Global Diabetes Institute, diabetes research, diabetes treatment.